Cyproheptadine: Difference between revisions
(created page on cyproheptadine) |
Neil.m.young (talk | contribs) (wikipedia not valid reference) |
||
| Line 42: | Line 42: | ||
==References== | ==References== | ||
*1. Boyer EW. Serotonin syndrome. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on January 11, 2016.) | *1. Boyer EW. Serotonin syndrome. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on January 11, 2016.) | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 12:43, 12 January 2016
Uses
- treatment of serotonin syndrome
Administration
- Dosage Forms: 4 mg tab, 2 mg/5ml solution
- Routes of Administration: oral
- Common Trade Names: Periactin or Peritol
Adult Dosing
- initial dose of 12 mg is recommended, followed by 2 mg every two hours until clinical response is seen
Pediatric Dosing
- Children younger than two years can be given approximately 0.06 mg/kg per dose every six hours, if needed (not to exceed 0.25 mg/kg/day).
- Children two to six years can be given 2 mg every six hours, if needed (not to exceed 12 mg/day).
- Children 7 to 14 years can be given 4 mg every six hours, if needed (not to exceed 16 mg/day).
Special Populations
Renal Dosing
- no recommendations
Hepatic Dosing
- no recommendations
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- hypotension
Common
- sedation
Mechanism of Action
- histamine-1 receptor antagonist with nonspecific 5-HT1A and 5-HT2A antagonistic properties. It also has weak anticholinergic activity.
Comments
See Also
References
- 1. Boyer EW. Serotonin syndrome. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on January 11, 2016.)
